Billionaire Hedge Fund Manager Up's Stake In Palantir...Market Heads Higher

In partnership with

Hey Options Trader,

We have a lot to cover in today’s newsletter. I added more Palantir on Monday and of course, a billionaire hedge fund manager upped his position by 500%. Don’t worry if you didn’t get in. I have a strategy for you at the end of this email.

Here’s what we are covering:

1. QQQ and the overall markets, why we are headed higher.

2. NVDA - The darling child is finally warming up to breakout to $160+

3. PLTR - Which hedge fund manager bought and how I would add more if you haven’t yet

QQQ and the Fed decision coming up on the 18th

The S&P 500 and Nasdaq 100 both made new all time highs today. This was partially sparked by a 75% probability the Federal Reserve will make yet another interest rate cut on the 18th of December.

This is good for markets. If the US government, banks, and consumers can borrow at lower rates, the Federal Reserve will have to create more money. This means more liquidity will be injected into the markets and consumers and businesses will be spending more than ever.

Right now we are in no man’s land. QQQ could be headed to $535, but I would like to see some more consolidation at these price levels for this move to be sustainable.

I control 500 shares via stock and LEAPS. I also rolled up my covered call today as I don’t want my shares to be called away this early in the bull run.

Natural Is planning to list on the Nasdaq

Natural solutions are already better for the environment. Med-X is taking it a step further: their natural pesticides outperform various chemical alternatives. Better yet, they’re taking on private investors as they plan their Nasdaq listing (ticker: MXRX). And you now have a limited time to invest before it happens. Med-X has had 200% revenue growth in five years. And with the pesticide market expected to grow 3X by the end of the decade, now is the perfect time to join them.

Invest Before Their Nasdaq Plans

$NVDA - the darling child is waking up again for another leg up!

If you aren’t aware, I currently have a $150k position in $NVDA as I believe it’s coiling up for another all time high. It’s currently trading in the middle of the bollinger bands which I believe is still a fair price entry. I don’t plan on adding more to my position at this point.

Next earnings is February 26th. I believe we run up to $170 into earnings.

$PLTR - Which hedge fund upped their position by 500%

None other than Ray Dalio, founder of Bridgewater Associates, sold some of their stake in $NVDA to buy Palantir. This indicates hedge funds are moving from AI manufactures and chip stocks to Ai software stocks for more risk.

This is exactly what I saw when NVDA started to plateau after earnings and PLTR still looked strong.

That is why I decided to purchase 5 additional LEAPS on monday bringing my total position to 10 LEAPS and 3 cash secured puts.

Palantir continues to crush earnings and secure new contracts which they did on Friday of last week.

I will start trimming my position once PLTR hits $140.

I may also add a few more LEAPS on any dips we get…if we get them.

MY PLTR STRATEGY EXPLAINED

Enjoy!

-Ryan